Tag: CBT > DEA Scheduling: Page 6

Cannabis Rescheduling

US Congressman Urges DEA to Expedite Rescheduling Cannabis

Rep. Steve Cohen of Tennessee wrote a letter to Administrator Anne Milgram pushing to initiate the rulemaking process “quickly.”

January 5, 2024

Cannabis Rescheduling

Industry Attorney Weighs in on Possible Cannabis Rescheduling Timeline: ‘It Normally Takes Years and Years for This to Get Done’

Despite the U.S. Drug Enforcement Administration’s recent response to a letter from Rep. Earl Blumenauer urging the agency to deschedule cannabis, Porter Wright Morris & Arthur’s Shane Pennington says it could be after the 2024 election before federal officials come to a decision on cannabis’s Schedule I status.

January 4, 2024

Florida

5 Cannabis Policy Reform Efforts to Watch in 2024

From the SAFER Banking Act to state-level reform, Akerman’s Jonathan Robbins outlines the legislation and potential policy changes on the horizon for the industry.

December 27, 2023

Cannabis Rescheduling

Former US Attorneys Urge Federal Officials to Reject Cannabis Rescheduling Recommendation

Eric Berlin, partner at Dentons, shares insight into some of the arguments the 29 former attorneys make against removing cannabis from Schedule I of the Controlled Substances Act.

December 21, 2023

Georgia

‘We Won’t Stop Working for Patient Access’: Georgia Regulators Weigh Options After Receiving DEA Warning About Pharmacies Dispensing Medical Cannabis

Georgia Access to Medical Cannabis Commission members said during a Dec. 13 meeting that the DEA’s recent warning highlights conflicting federal and state cannabis policy and they plan to continue fighting for patient access.

December 14, 2023

Colorado

6 Governors Push Biden to Reschedule Cannabis Before Year’s End

Head executives from Colorado, Illinois, Louisiana, Maryland, New Jersey and New York penned the letter to the White House.

December 6, 2023

Ohio

The Top 10: CBT's Most-Read Articles in November

Here's a recap and list of the stories readers engaged most with this month.

November 29, 2023

Cannabis Rescheduling

US Sen. Kirsten Gillibrand Calls on DEA to Reclassify Cannabis as Schedule III

The New York Democrat says cannabis “is simply not comparable to other Schedule I substances like heroin, LSD and MDMA.”

November 21, 2023

Interviews & Opinion

A Positive Sign For Schedule III

In Vienna, a U.S. state department legal adviser champions member-state discretion over domestic drug policy, potentially removing the obstacle the Single Convention drug treaty could pose to cannabis reform.

November 7, 2023

Cannabis Rescheduling

31 Bipartisan House Lawmakers Urge DEA to End ‘Failed’ Cannabis Prohibition

A group of U.S. representatives sent a letter to DEA Administrator Anne Milgram calling on her agency to “recognize the merits of full descheduling.”

November 1, 2023

Cannabis Rescheduling

Rescheduling Cannabis: Would 1961 Drug Treaty Be a Possible Wrench?

Reclassifying cannabis to a Schedule III drug would put the U.S. in noncompliance with the international treaty Single Convention on Narcotic Drugs, 1961. Will this create a barrier for the U.S. in its scheduling review, and if so, to what extent? Historian James H. Mills weighs in.

October 5, 2023

Cannabis Rescheduling

‘Descheduling Would Not Be Utopia’

Shane Pennington of Porter Wright Morris & Arthur addresses some of the biggest questions and concerns surrounding cannabis rescheduling, including the role of the FDA and Big Pharma.

September 26, 2023